Patent details
EP2793876 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS
Basic Information
- Publication number:
- EP2793876
- PCT Application Number:
- EP2012074915
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP128015393
- PCT Publication Number:
- WO2013092269
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS
- French Title of Invention:
- COMPOSITIONS PHARMACEUTIQUES DES GLITAZONES ET DES ACTIVATEURS DE NRF2
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT GLITAZONEN UND NRF2 AKTIVATOREN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 04/10/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 23/10/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 04/10/2023
- Unitary Effect Registration Date:
- 23/10/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 10/12/2012
- Grant date:
- 04/10/2023
- EP Publication Date:
- 29/10/2014
- PCT Publication Date:
- 27/06/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/10/2023
- EP B1 Publication Date:
- 04/10/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 10/12/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/09/2023
- Name:
- Kahrs, Bjoern Colin
- Address:
- Via Costa di Mezzo 54, 6614 Brissago, Switzerland (CH)
Inventor
- Name:
- Kahrs, Bjoern Colin
- Address:
- Switzerland (CH)
Priority
1
- Priority Number:
- 11194292
- Priority Date:
- 19/12/2011
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 12004652
- Priority Date:
- 21/06/2012
- Priority Country:
- European Patent Office (EPO) (EP)
3
- Priority Number:
- 201261663761 P
- Priority Date:
- 25/06/2012
- Priority Country:
- United States (US)
4
- Priority Number:
- 201213654632
- Priority Date:
- 18/10/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/225; A61K 31/4439; A61K 31/70; A61K 45/06; A61P 17/06; A61P 1/04; A61P 17/14; A61P 5/48; A61P 21/04; A61K 31/05; A61K 31/12; A61K 31/16; A61K 31/19; A61K 31/216; A61K 31/26; A61K 31/385; A61K 31/47;
Publication
European Patent Bulletin
1
- Issue number:
- 202340
- Publication date:
- 04/10/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202345
- Publication date:
- 08/11/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202347
- Publication date:
- 22/11/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|